Stay updated on Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial

Sign up to get notified when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The record provides details of the completed Phase 2 pimavanserin study for major depressive disorder, including its eligibility criteria, locations, study design, and measured outcomes. It also includes study documents, results-related dates, and publications.
    Difference
    62%
    Check dated 2026-11-08T14:32:48.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now identifies the website release as v3.8.0 instead of v3.7.2.
    Difference
    0.2%
    Check dated 2026-11-01T15:49:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A site-wide notice announces that NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” in some content.
    Difference
    1%
    Check dated 2026-10-25T15:44:51.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site's footer revision identifier updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-18T22:17:03.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-11T22:09:25.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.7.0 tag. A large set of study documents and related entries (e.g., Statistical Analysis Plan, Study Protocol, IPD plans, and provider details) were removed from the Study Documents section, changing the accessibility of key materials for the trial.
    Difference
    18%
    Check dated 2026-09-20T19:57:13.000Z thumbnail image

Stay in the know with updates to Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adjunctive Pimavanserin in Major Depressive Disorder Clinical Trial page.